targeted drug delivery device market

Global Targeted Drug Delivery Device Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027

  • Published Date: 2021-03-24
  • Report ID: 78569
  • Pages: 126
  • Format: prudent report format

Summary

As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.

Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales.Prudent Markets published a report for global Targeted Drug Delivery Device market in this environment.

In terms of revenue, this research report indicated that the global Targeted Drug Delivery Device market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Targeted Drug Delivery Device industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.

The 4D Molecular Therapeutics aims at producing XX K Units Targeted Drug Delivery Device in 2020, with XX % production to take place in global market, AbbVie accounts for a volume share of XX %.

Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Targeted Drug Delivery Device Market byPrudent Markets Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Targeted Drug Delivery Device Market
4D Molecular Therapeutics
AbbVie
Abeona Therapeutics
Advaxis
Alcyone Lifesciences
AlphaVax
Amgen
Amicus Therapeutics
Anaeropharma Science
AnGes
AskBio
Astellas Pharma
AstraZeneca
Athersys
BioCardia
Biogen
BioInvent
BioRestorative Therapies
Bluebird bio
Boston Scientific
CellProthera
Celsion
Celyad
Evonik
Kadimastem
Medtronic
Novartis
Sanofi
SOTIO
Takeda
...
Major Type of Targeted Drug Delivery Device Covered inPrudent Markets report:
Eye
Brain
Heart
Breast
Abdomen
Others
Application Segments Covered inPrudent Markets Market
Metabolic Disorder
Ophthalmic Disease
Oncological Disorder
Neurological Disorder
Cardiovascular Disorder
Others

For any other requirements, please feel free to contact us and we will provide you customized report.


Table of Contents

Global Targeted Drug Delivery Device Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Eye -Product Introduction and Major Manufacturers
1.1.2 Brain -Product Introduction and Major Manufacturers
1.1.3 Heart -Product Introduction and Major Manufacturers
1.1.4 Breast -Product Introduction and Major Manufacturers
1.1.5 Abdomen -Product Introduction and Major Manufacturers
1.1.6 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Targeted Drug Delivery Device Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)
3 Regional Market Analysis
3.1 China Targeted Drug Delivery Device Market
3.1.1 Top Companies leading Targeted Drug Delivery Device Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China Targeted Drug Delivery Device Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)
3.2 EU Targeted Drug Delivery Device Market
3.2.1 Top Companies leading Targeted Drug Delivery Device Development in EU (2016-2021)
3.2.2 Sales Value of Major Company in EU Market (2016-2021)
3.2.3 EU Targeted Drug Delivery Device Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2026-2027)
3.3 USA Targeted Drug Delivery Device Market
3.3.1 Top Companies leading Targeted Drug Delivery Device Development in USA (2016-2021)
3.3.2 Sales Value of Major Company in USA Market (2016-2021)
3.3.3 USA Targeted Drug Delivery Device Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2026-2027)
3.4 Japan Targeted Drug Delivery Device Market
3.4.1 Top Companies leading Targeted Drug Delivery Device Development in Japan (2016-2021)
3.4.2 Sales Value of Major Company in Japan Market (2016-2021)
3.4.3 Japan Targeted Drug Delivery Device Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2026-2027)
3.5 India Targeted Drug Delivery Device Market
3.5.1 Top Companies leading Targeted Drug Delivery Device Development in India (2016-2021)
3.5.2 Sales Value of Major Company in India Market (2016-2021)
3.5.3 India Targeted Drug Delivery Device Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2026-2027)
3.6 Southeast Asia Targeted Drug Delivery Device Market
3.6.1 Top Companies leading Targeted Drug Delivery Device Development in Southeast Asia (2016-2021)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021)
3.6.3 Southeast Asia Targeted Drug Delivery Device Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
3.7 South America Targeted Drug Delivery Device Market
3.7.1 Top Companies leading Targeted Drug Delivery Device Development in South America (2016-2021)
3.7.2 Sales Value of Major Company in South America Market (2016-2021)
3.7.3 South America Targeted Drug Delivery Device Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2026-2027)
4 Value Chain (Impact of COVID-19)
4.1 Targeted Drug Delivery Device Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Targeted Drug Delivery Device Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2027)
5.1 Global Targeted Drug Delivery Device Sales and Growth Rate (2021-2027)
5.2 Global Targeted Drug Delivery Device Sales Value and Growth Rate (2021-2027)

6 Targeted Drug Delivery Device Competitive Analysis
6.1 4D Molecular Therapeutics
6.1.1 4D Molecular Therapeutics Company Profiles
6.1.2 4D Molecular Therapeutics Product Introduction
6.1.3 4D Molecular Therapeutics Targeted Drug Delivery Device Production, Revenue (2016-2021)
6.1.4 SWOT Analysis
6.2 AbbVie
6.2.1 AbbVie Company Profiles
6.2.2 AbbVie Product Introduction
6.2.3 AbbVie Targeted Drug Delivery Device Production, Revenue (2016-2021)
6.2.4 SWOT Analysis
6.3 Abeona Therapeutics
6.3.1 Abeona Therapeutics Company Profiles
6.3.2 Abeona Therapeutics Product Introduction
6.3.3 Abeona Therapeutics Targeted Drug Delivery Device Production, Revenue (2016-2021)
6.3.4 SWOT Analysis
6.4 Advaxis
6.4.1 Advaxis Company Profiles
6.4.2 Advaxis Product Introduction
6.4.3 Advaxis Targeted Drug Delivery Device Production, Revenue (2016-2021)
6.4.4 SWOT Analysis
6.5 Alcyone Lifesciences
6.5.1 Alcyone Lifesciences Company Profiles
6.5.2 Alcyone Lifesciences Product Introduction
6.5.3 Alcyone Lifesciences Targeted Drug Delivery Device Production, Revenue (2016-2021)
6.5.4 SWOT Analysis
6.6 AlphaVax
6.6.1 AlphaVax Company Profiles
6.6.2 AlphaVax Product Introduction
6.6.3 AlphaVax Targeted Drug Delivery Device Production, Revenue (2016-2021)
6.6.4 SWOT Analysis
6.7 Amgen
6.7.1 Amgen Company Profiles
6.7.2 Amgen Product Introduction
6.7.3 Amgen Targeted Drug Delivery Device Production, Revenue (2016-2021)
6.7.4 SWOT Analysis
6.8 Amicus Therapeutics
6.8.1 Amicus Therapeutics Company Profiles
6.8.2 Amicus Therapeutics Product Introduction
6.8.3 Amicus Therapeutics Targeted Drug Delivery Device Production, Revenue (2016-2021)
6.8.4 SWOT Analysis
6.9 Anaeropharma Science
6.9.1 Anaeropharma Science Company Profiles
6.9.2 Anaeropharma Science Product Introduction
6.9.3 Anaeropharma Science Targeted Drug Delivery Device Production, Revenue (2016-2021)
6.9.4 SWOT Analysis
6.10 AnGes
6.10.1 AnGes Company Profiles
6.10.2 AnGes Product Introduction
6.10.3 AnGes Targeted Drug Delivery Device Production, Revenue (2016-2021)
6.10.4 SWOT Analysis
6.11 AskBio
6.12 Astellas Pharma
6.13 AstraZeneca
6.14 Athersys
6.15 BioCardia
6.16 Biogen
6.17 BioInvent
6.18 BioRestorative Therapies
6.19 Bluebird bio
6.20 Boston Scientific
6.21 CellProthera
6.22 Celsion
6.23 Celyad
6.24 Evonik
6.25 Kadimastem
6.26 Medtronic
6.27 Novartis
6.28 Sanofi
6.29 SOTIO
6.30 Takeda
7 Conclusion


CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.